• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Charles River Laboratories Intl (NY: CRL )

    196.96 UNCHANGED
    Streaming Delayed Price Updated: 7:00 PM EDT, Aug 28, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 196.96
    Bid (Size) 79.17 (1)
    Ask (Size) 237.88 (2)
    Prev. Close 196.96
    Today's Range 196.96 - 196.96
    52wk Range 161.65 - 275.00
    Shares Outstanding 50,396,622
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Warner Bros, Airbnb And Monster Beverage Are Among Top 10 Large Cap Losers Last Week (Aug 4-Aug 10): Are The Others In Your Portfolio?
    These 10 stocks had the biggest drop last week, with McKesson Corporation, BIO-TECHNE Corp, and Warner Bros. Discovery, Inc. being the worst performers. 
    Via Benzinga

    Performance

    YTD
    -15.92%
    -15.92%
    1 Month
    -17.22%
    -17.22%
    3 Month
    -6.87%
    -6.87%
    6 Month
    -23.28%
    -23.28%
    1 Year
    -3.40%
    -3.40%

    More News

    Read More
    EXCLUSIVE: Oragenics' Concussion Drug Clears FDA-Required Cardiotoxicity Testing, Planning For Phase Trials Underway
    Via Benzinga
    Critical Insights From Charles River Analyst Ratings: What You Need To Know
    Via Benzinga
    Demystifying Charles River: Insights From 4 Analyst Reviews
    Via Benzinga
    The Analyst Verdict: Charles River In The Eyes Of 4 Experts
    Via Benzinga
    Boot Barn To Rally Around 27%? Here Are 10 Top Analyst Forecasts For Thursday
    Via Benzinga
    Wall Street Ends Wednesday In The Red As Risk Sentiment Remains Fragile: S&P 500 Movers At The Close
    Via Benzinga
    Topics Economy Stocks
    Exposures Interest Rates US Equities
    Charles River Laboratories Stock Sinks As It Warns Of Continued Biotech Demand Slump, Lowers Forecast
    Via Benzinga
    Charles River Labs Plummets 17% On 'Bleaker' Expectations For 2024
    Via Investor's Business Daily
    The Analyst Landscape: 7 Takes On Charles River
    Via Benzinga
    Charles River Laboratories Announces Second-Quarter 2024 Results
    From Charles River Laboratories International, Inc.
    Via Business Wire
    Charles River Collaborates with Patient Advocacy Group, FOXG1 Research Foundation to Advance Rare Disease Gene Therapy Development
    From Charles River Laboratories International, Inc.
    Via Business Wire
    Charles River Laboratories and Autobahn Labs Announce Collaborative Program to Accelerate Academic Drug Discovery
    From Charles River Laboratories International, Inc.
    Via Business Wire
    Charles River Laboratories Schedules Second-Quarter 2024 Earnings Release and Conference Call
    From Charles River Laboratories International, Inc.
    Via Business Wire
    Apple To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Wednesday
    Via Benzinga
    Charles River to Perform Plasmid Manufacturing for AAVantgarde
    From Charles River Laboratories International, Inc.
    Via Business Wire
    These Nike Analysts Are No Longer Bullish; Here Are Top 5 Downgrades For Friday
    Via Benzinga
    Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus
    From Charles River Laboratories International, Inc.
    Via Business Wire
    Charles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell Therapy
    From Charles River Laboratories International, Inc.
    Via Business Wire
    Charles River Laboratories, in Collaboration With MatTek Corporation, Awarded Grant from the Foundation for Chemistry Research and Initiatives to Advance Research Alternatives
    From Charles River Laboratories International, Inc.
    Via Business Wire
    Charles River Laboratories Expands Access to CRADL® Contract Vivarium Space in Somerville
    From Charles River Laboratories International, Inc.
    Via Business Wire
    Charles River Laboratories Announces Development of Nonclinical Virtual Control Groups with Sanofi to Reduce the Use of Animals in Research
    From Charles River Laboratories International, Inc.
    Via Business Wire
    Charles River Laboratories to Present at William Blair and Jefferies Conferences
    From Charles River Laboratories International, Inc.
    Via Business Wire
    Charles River Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development
    From Charles River Laboratories International, Inc.
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.